Skip to main content
. 2003 Apr 15;31(8):2157–2167. doi: 10.1093/nar/gkg317

Figure 4.

Figure 4

End protection by DNA ligase IV–XRCC4 protein can occur in the absence of DNA end joining. Protein extracts (40 µg) prepared from control lymphoblastoid cell lines, AHH1 and Nalm-6, the LIG4 syndrome cell line LB2304 and the LIG4-null cell line N114P2 were incubated with a non-ligatable 5′-32P-end-labeled substrate (20 ng). Recombinant DNA ligase IV–XRCC4 (180 ng) was added where shown. Product formation was analyzed by agarose gel electrophoresis followed by autoradiography.